BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24232731)

  • 41. Nutrition, the gut microbiome and the metabolic syndrome.
    Kovatcheva-Datchary P; Arora T
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):59-72. PubMed ID: 23768553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gut microbiome and obesity.
    Hullar MA; Lampe JW
    Nestle Nutr Inst Workshop Ser; 2012; 73():67-79. PubMed ID: 23128767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of added feed enzymes in promoting gut health in swine and poultry.
    Kiarie E; Romero LF; Nyachoti CM
    Nutr Res Rev; 2013 Jun; 26(1):71-88. PubMed ID: 23639548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle wasting: the gut microbiota as a new therapeutic target?
    Bindels LB; Delzenne NM
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2186-90. PubMed ID: 23831839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function.
    Kanauchi O; Andoh A; Mitsuyama K
    J Agric Food Chem; 2013 Oct; 61(42):9977-83. PubMed ID: 24070265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
    Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
    Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity and NAFLD: the role of bacteria and microbiota.
    Duseja A; Chawla YK
    Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Gut Microbiota in the Aetiology of Obesity: Proposed Mechanisms and Review of the Literature.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    J Obes; 2016; 2016():7353642. PubMed ID: 27703805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reshaping the gut microbiota at an early age: functional impact on obesity risk?
    Luoto R; Collado MC; Salminen S; Isolauri E
    Ann Nutr Metab; 2013; 63 Suppl 2():17-26. PubMed ID: 24217033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Obesity and the gut microbiome: pathophysiological aspects.
    Bradlow HL
    Horm Mol Biol Clin Investig; 2014 Jan; 17(1):53-61. PubMed ID: 25372730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.
    Cani PD
    Clin Microbiol Infect; 2012 Jul; 18 Suppl 4():50-3. PubMed ID: 22647050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomics, human gut microbiota and probiotics.
    Aires J; Butel MJ
    Expert Rev Proteomics; 2011 Apr; 8(2):279-88. PubMed ID: 21501019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut microbiota, nutrient sensing and energy balance.
    Duca FA; Lam TK
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():68-76. PubMed ID: 25200299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between gut microbiota and development of T cell associated disease.
    Kosiewicz MM; Dryden GW; Chhabra A; Alard P
    FEBS Lett; 2014 Nov; 588(22):4195-206. PubMed ID: 24681103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal microbiota in inflammation and insulin resistance: relevance to humans.
    De Bandt JP; Waligora-Dupriet AJ; Butel MJ
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):334-40. PubMed ID: 21587065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gut microbiota in health and disease].
    Icaza-Chávez ME
    Rev Gastroenterol Mex; 2013; 78(4):240-8. PubMed ID: 24290319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obesity, inflammation, and the gut microbiota.
    Cox AJ; West NP; Cripps AW
    Lancet Diabetes Endocrinol; 2015 Mar; 3(3):207-15. PubMed ID: 25066177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways.
    Hagland HR; Søreide K
    Cancer Lett; 2015 Jan; 356(2 Pt A):273-80. PubMed ID: 24614287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The guts of obesity: progress and challenges in linking gut microbes to obesity.
    Al-Ghalith GA; Vangay P; Knights D
    Discov Med; 2015 Feb; 19(103):81-8. PubMed ID: 25725222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.